Loss of MMR is a practical and safe criterion for restarting therapy in patients with CML with prolonged CMR.
No takes yet. Share an insight, caveat, or question.
Rousselot et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: